iSign Solutions (ISGN) 10-Q 15 Aug 16 2016 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	6 Months Ended
	Jun. 30, 2016	Aug. 15, 2016	Jun. 30, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	iSign Solutions Inc.
Entity Central Index Key	727,634
Document Type	10-Q
Document Period End Date	Jun. 30, 2016
Amendment Flag	false
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q2
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
EntityVoluntaryFilers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		5,498,246
Entity Public Float			$ 4,203,038

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Cash and cash equivalents	$ 455	$ 846
Accounts receivable, net of allowance of $30 at June 30, 2016 and $22 at December 31, 2015, respectively	196	94
Prepaid expenses and other current assets	55	372
Total current assets	706	1,312
Property and equipment, net	38	44
Intangible assets, net	430	591
Other assets	29	29
Total assets	1,203	1,976
Current liabilities:
Accounts payable	1,331	787
Short-term notes payable	190	991
Accrued compensation	297	263
Other accrued liabilities	410	615
Deferred revenue	339	384
Short-term capital lease	3
Derivative liability	156	330
Total current liabilities	2,726	3,370
Deferred revenue long-term	385	455
Long-term capital lease	11
Other long-term liabilities	14	21
Total liabilities	3,136	3,846
Commitments and Contingencies
Equity (deficit)
Common stock	55	2
Treasury stock	(325)	(325)
Additional paid in capital	(128,282)	95,312
Accumulated deficit	(129,395)	(127,116)
Accumulated other comprehensive loss	(14)	(14)
Total iSign stockholder's deficit	(1,397)	(1,334)
Non-controlling interest	(536)	(536)
Total deficit	(1,933)	(1,870)
Total liabilities and deficit	$ 1,203	1,976
Series A-1 Preferred Stock [Member]
Equity (deficit)
Preferred stock by class of stock		947
Series B Preferred Stock [Member]
Equity (deficit)
Preferred stock by class of stock		11,653
Series C Preferred Stock [Member]
Equity (deficit)
Preferred stock by class of stock		6,069
Series D-1 Preferred Stock [Member]
Equity (deficit)
Preferred stock by class of stock		6,866
Series D-2 Preferred Stock [Member]
Equity (deficit)
Preferred stock by class of stock		$ 5,272

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Current assets:
Accounts receivable, allowance	$ 30	$ 22

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenue:
Product	$ 164	$ 153	$ 224	$ 384
Maintenance	192	214	409	430
Total revenues	356	367	633	814
Cost of sales:
Product	17	34	54	145
Maintenance	85	61	218	73
Research and development	367	498	685	1,021
Sales and marketing expense	127	242	329	540
General and administrative expense	613	561	1,342	1,082
Total operating costs and expenses	1,209	1,396	2,628	2,861
Loss from operations	(853)	(1,029)	(1,995)	(2,047)
Other expense, net	(16)		(13)
Interest expense:
Related party	(30)		(81)
Other	(38)	(1)	(98)	(1)
Amortization of debt discount:
Related Party	(34)		(56)
Other	(127)		(210)
Gain on derivative liability	149	1	174	17
Net loss	(949)	(1,029)	(2,279)	(2,031)
Accretion of beneficial conversion feature, preferred shares:
Related party			(115)	(458)
Other			(130)	(69)
Preferred stock dividends:
Related party	(226)	(391)	(646)	(746)
Other	(233)	(394)	(667)	(770)
Net loss attributable to common stockholders	$ (1,408)	$ (1,814)	$ (3,837)	$ (4,074)
Basic and diluted loss per common share	$ (0.53)	$ (9.68)	$ (2.70)	$ (21.73)
Weighted average common shares outstanding, basic and diluted	2,636	187	1,420	187

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net loss	$ (2,279)	$ (2,031)
Adjustments to reconcile net loss to net cash used for operating activities:
Depreciation and amortization	183	178
Debt discount amortization	266
Stock-based employee compensation	106	371
Gain on derivative liability	(174)	(17)
Changes in operating assets and liabilities:
Accounts receivable, net	(102)	(34)
Prepaid expenses and other assets	317	37
Accounts payable	544	(5)
Accrued Compensation	34	(25)
Other accrued liabilities	405	34
Deferred revenue	(115)	(64)
Net cash used in operating activities	(815)	(1,556)
Cash flows from investing activities:
Acquisition of property and equipment		(10)
Net cash used in investing activities		(10)
Cash flows from financing activities:
Proceeds from issuance of Series D preferred Stock, net of issuance costs of $33		1,200
Proceeds from issuance of common stock and warrants, net of issuance costs of $780	424
Net cash provided by financing activities	424	1,200
Net decrease in cash and cash equivalents	(391)	(366)
Cash and cash equivalents at beginning of period	846	775
Cash and cash equivalents at end of period	455	409
Supplemental disclosure of cash flow information:
Interest paid	3	1
Income tax paid
Non-cash financing and investing transactions:
Aquisition of property and equipment through capital lease	15
Conversion of convertible notes plus accrued interest	1,188
Conversion of deferred compensation plus accrued interest	498
Dividends on preferred shares	1,313	1,516
Accretion of beneficial conversion feature on issuance of convertible Preferred Stock		498
Accretion of beneficial conversion feature on issuance of Preferred Stock dividends	$ 245	$ 29

Condensed Consolidated Stateme6

Condensed Consolidated Statement of Cash Flows (Parenthetical) - USD ($) shares in Thousands, $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Number of common shares issued in notes conversion	683
Number of common shares issued in deferred compensation conversion	286
Common Stock and Warrants [Member]
Issuance costs	$ 780
Series D Preferred Stock [Member]
Issuance costs		$ 33

Nature of business, basis of pr

Nature of business, basis of presentation and summary of significant accounting policies	6 Months Ended
	Jun. 30, 2016
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of business, basis of presentation and summary of significant accounting policies	1. Nature of Business and Summary of Significant Accounting Policies Nature of Business On January 21, 2016, iSign Solutions Inc. (the "Company" or "iSign") filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the "Certificate of Amendment") with the Secretary of State of the State of Delaware to effect a 1-for-1,250 reverse split of the Company's outstanding shares of common stock. The reverse split became effective on January 22, 2016. The information with respect to common stock for the period ended June 30, 2015 has been retroactively restated to give effect to the 1-for-1,250 reverse split. iSign Solutions Inc. and its subsidiary is a leading supplier of digital transaction management (DTM) software enabling the paperless, secure and cost-effective management and authentication of document-based transactions. iSign's solutions encompass a wide array of functionality and services, including electronic signatures, simple-to-complex workflow management and various options for biometric authentication. These solutions are available across virtually all enterprise, desktop and mobile environments as a seamlessly integrated platform for both ad-hoc and fully automated transactions. iSign's platform can be deployed both on premise and as a cloud-based ("SaaS") service, with the ability to easily transition between deployment models. The Company is headquartered in Redwood Shores, California. The Company's products include SignatureOne® Ceremony™ Server, the iSign® suite of products and services, including iSign® Enterprise and iSign® Console™, and Sign-it® programs. Basis of Presentation The financial information contained herein should be read in conjunction with the Company's consolidated audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2015. The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("GAAP") for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company's results of operations and cash flows for the periods presented. The Company's interim results are not necessarily indicative of the results to be expected for the entire year. Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at June 30, 2016, the Company's accumulated deficit was $129,395. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of June 30, 2016, the Company's cash balance was $455. These factors raise substantial doubt about the Company's ability to continue as a going concern. There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Accounting Changes and Recent Accounting Pronouncements In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. ASU 2016-01 requires all financial assets and liabilities not accounted for under the equity method to be measured at fair value with the changes in fair value recognized in net income. The amendments in this update also require an entity to separately present in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. In addition, the amendments in this update supersede the requirement to disclose the methods and significant assumptions used in calculating the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. Early adoption is not permitted except for the comprehensive income presentation requirement, and the updated guidance requires a prospective application with a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The guidance is effective for annual periods after December 15, 2017, and we are currently in the process of evaluating the impact of this new guidance. In February 2016, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) 2016, Leases (Topic 842) intended to improve financial reporting about leasing transactions which requires companies to report capital and operating leases with a term of 12 Months or longer on their balance sheets. Disclosure requirements of the leasing arrangement will include qualitative and quantitative information about the amounts recorded in the financial statements. The guidance is effective for annual periods after December 15, 2018, and we are currently in the process of evaluating the impact of this new guidance In March 2016 the FASB issued ASU No. 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 provides for simplification involving several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. In addition to these simplifications, ASU 2016-09 also eliminates the guidance in Topic 718 that was indefinitely deferred shortly after the issuance of FASB Statement No. 123 (revised 2004), Share-Based Payment. Early adoption is permitted and the application of the guidance is different for each update included within ASU 2016-09. The guidance is effective for annual periods after December 15, 2016, and we are currently in the process of evaluating the impact of this new guidance. In May 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-12 Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients. ASU 2016-12 provides for improvements and practical expedients for specific areas of Topic 606. In April 2016, the FASB issued ASU No. 2016-10 Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 provides for clarification of two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance. In March 2016, the FASB issued ASU No. 2016-08Revenue from Contracts with Customers (Topic 606) - Principal versus Agent Considerations (Reporting Revenue Gross versus Net). ASU No. 2016-08 requires an entity to determine whether the nature of its promise to provide goods or services to a customer is performed in a principal or agent capacity and to recognize revenue in a gross or net manner based on its principal/agent designation. ASUs 2016-12, 2016-10 and 2016-08 allow for companies to choose to apply the standard retrospectively to each prior reporting period presented (full retrospective application) or retrospectively with the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings of the annual reporting period that includes the date of initial application (modified retrospective application). Each guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Early application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. We are currently in the process of evaluating these guidance updates. iSign is in the process of evaluating the impact of this new guidance on the Company's financial position, results of operations and cash flows.

Concentrations

Concentrations	6 Months Ended
	Jun. 30, 2016
Risks and Uncertainties [Abstract]
Concentration Risk Disclosure [Text Block]	2. Concentrations The following table summarizes accounts receivable and revenue concentrations: Accounts Receivable Total Revenue Total Revenue 2016 2015 2016 2015 2016 2015 Customer #1 33% 19% - - - - Customer #2 - 32% - 11% - 13% Customer #3 - - - 10% 11% 19% Customer #4 48% 31% 38% 28% 27% 16% Customer #5 - - - - 11% - Total concentration 81% 82% 38% 49% 49% 48%

Intangible Assets

Intangible Assets	6 Months Ended
	Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	3. Intangible assets The Company performs an intangible asset impairment analysis at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets. Management completed an analysis of the Company's intangible assets as of December 31, 2015. Based on that analysis, the Company concluded that no impairment of the carrying value of the intangible assets existed. The Company believes that no events or circumstances changed during the three and six months ended June 30, 2016 that would impact this conclusion. Amortization of intangible assets costs was $80 and $161 for the three and six-month periods ended June 30, 2016 and $86 and $173 for the three and six-month periods ended June 30, 2015, respectively. The following table summarizes the patents: June 30, 2016 December 31, 2015 Carrying Accumulated Net Value Carrying Accumulated Net Value Amortizable Technology $ 6,745 $ (6,315) $ 430 $ 6,745 $ (6,154) $ 591

Net loss per share

Net loss per share	6 Months Ended
	Jun. 30, 2016
Net loss per share [Abstract]
Net loss per share	4. Net Loss per Share The Company calculates basic net loss per share based on the weighted average number of shares outstanding, and when applicable, diluted net income per share, which is based on the weighted average number of shares and potential dilutive shares outstanding. The Company's Preferred Shareholders converted all of their Preferred Stock into shares of Common Stock on May 19, 2016. The following table lists shares and warrants that were excluded from the calculation of diluted earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive: For the Six Months Ended June 30, 2016 June 30, 2015 Stock options 74 85 Warrants 1,756 179 Preferred Stock as if converted Series A-1 Preferred Stock - 5 Series B Preferred Stock - 237 Series C Preferred Stock - 185 Series D-1 Preferred Stock - 261 Series D-2 Preferred Stock - 97

Debt

Debt	6 Months Ended
	Jun. 30, 2016
Short-term notes payable [Abstract]
Debt	5. Debt Short-term notes payable: In the fourth quarter of 2015, the Company entered into unsecured convertible promissory note purchase agreements with investors and affiliates of the Company aggregating $1,268 in cash. Promissory notes with a principal amount of $1,068 plus accrued interest converted into shares of our Common Stock on May 19, 2016. The notes and accrued interest converted at a price of $1.74 per share into 683 shares of our Common Stock. The holders of the notes also received 854 warrants to purchase 854 shares of Common Stock. Such warrants have a 5 year term and are exercisable at a price of $2.175 per share. The Company ascribed a relative fair value to the warrants using the Black-Scholes-Merton valuation model of $586, which was charged to additional paid-in capital during the quarter ended June 30, 2016. One promissory note with a principal amount of $190, net of $10 in unamortized discount, remains outstanding as of June 30, 2016. This note bears interest at a rate of 24% per year and is due on August 25, 2016. The note can be converted into shares of our Common Stock at the holder's option for a period of 60 days after maturity, at a conversion price based upon a Company pre-money valuation of $5,000. Upon such conversion, the holder would also receive cash payments, payable from 3% of the revenue received by the Company from its European customer, not to exceed three times the aggregate principal amount of $200.

Derivative Liability

Derivative Liability	6 Months Ended
	Jun. 30, 2016
Derivative liability [Abstract]
Derivative Liability	6. Derivative Liability The Company has determined that a contract that would otherwise meet the definition of a derivative but is both (a) indexed to the Company's own stock and (b) classified in stockholders' deficit in the statement of financial position would not be considered a derivative financial instrument. The Company applies a two-step model in determining whether a financial instrument or an embedded feature is indexed to an issuer's own stock and thus able to qualify for the scope exception. In November and December 2015, the Company entered into unsecured convertible promissory note purchase agreements with investors and affiliates of the Company. The accounting for the unsecured convertible notes, which are convertible into shares of our common stock, requires us to bifurcate the conversion feature and account for it as a derivative liability at the estimated fair value upon issuance. The Company used a Monte Carlo simulation to value the conversion feature with the following assumptions: As of June 30, 2016 Common Stock price $ 1.31 Convertible debt principal amount $ 200 Term (years) 0.32 Expected volatility 108% Convertible debt interest rate 24% Trials (each trial equals 150,000 iterations) 10 Discount to IPO/next round Based upon a Company pre-money valuation of $5,000 The fair value framework requires a categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. There were no financial assets or liabilities measured at fair value, with the exception of cash and cash equivalents (level 1) and the above mentioned derivative liability (level 3) as of June 30, 2016 and December 31, 2015, respectively. Changes in the fair market value of the Level 3 derivative liability for the six-month periods ended June 30, 2016 and June 30, 2015 are as follows: For the Six Months Ended June 30, 2016 June 30, 2015 Balance at January 1 $ 330 $ - Net gain on derivative liability (174) - Balance at June 30 $ 156 $ -

Equity

Equity	6 Months Ended
	Jun. 30, 2016
Stockholders' Equity [Abstract]
Stockholders' Equity	7. Equity (Deficit) Stock-based compensation expense is based on the estimated grant date fair value of the portion of stock-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes-Merton valuation model. Forfeitures of stock-based payment awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The estimated average forfeiture rate for the three months ended June 30, 2016 and 2015, was approximately 11.89% and 7.54%, respectively, based on historical data. Valuation and Expense Information: The weighted-average fair value of stock-based compensation is based on the Black-Scholes-Merton valuation model. Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options. The fair value calculations are based on the following assumptions: Six Months Ended Six Months Ended Risk free interest rate 0.04% - 3.19% 0.04% - 3.73% Expected life (years) 2.82 - 7.00 3.26 - 6.88 Expected volatility 112.75% - 198.90% 93.63% - 198.38% Expected dividends None None There were no stock options granted, and no stock options exercised during the three and six months ended June 30, 2016. The Company granted 29 stock options during the three and six months ended June 30, 2015 at a weighted average exercise price of $28.13 per share. There were no stock options exercised during the three and six months ended June 30, 2015. The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and six months ended June 30: Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Research and development $ 15 $ 47 $ 34 $ 113 Sales and marketing $ 2 $ 34 $ 15 $ 86 General and administrative $ 19 $ 65 $ 43 $ 145 Director options $ 6 $ 12 $ 14 $ 27 Total stock-based compensation expense $ 42 $ 158 $ 106 $ 371 A summary of option activity under the Company's plans for the six months ended June 30, 2016 and 2015 is as follows: Options 2016 2015 Shares Weighted Price Per Share Weighted Life (Years) Aggregate Value Shares Weighted Price Per Share Weighted Life (Years) Aggregate Value Outstanding at January 1, 82 $ 45.35 $ - 57 $ 56.13 $ - Granted - $ - $ - 29 $ 28.13 $ - Exercised - $ - $ - - $ - $ - Forfeited or expired (8) $ 42.16 $ - (1) $ 37.50 $ - Outstanding at June 30 74 $ 45.71 3.65 $ - 85 $ 46.75 4.59 $ - Vested and expected to vest at June 30 72 $ 46.22 3.10 $ - 83 $ 37.50 3.24 $ - Exercisable at June 30 58 $ 51.10 3.10 $ - 52 $ 56.00 3.56 $ - The following table summarizes significant ranges of outstanding and exercisable options as of June 30, 2016: Range of Exercise Prices Options Outstanding Options Exercisable Number Weighted Weighted Number Weighted $25.00 - $625.00 74 3.65 $ 45.71 58 $ 51.10 A summary of the status of the Company's non-vested shares as of June 30, 2016 is as follows: Non-vested Shares Shares Weighted Non-vested at January 1, 2016 25 $28.61 Forfeited (3) $28.80 Vested (6) $46.22 Non-vested at June 30, 2016 16 $26.42 As of June 30, 2016, there was a total of $107 of unrecognized compensation expense related to non-vested stock-based compensation arrangements granted under the plans. The unrecognized compensation expense is expected to be realized over a weighted average period of 1.7 years. Sale of Common Stock and Conversion of Preferred Stock, Short-term Debt and Deferred Compensation On May 19, 2016, the Company closed an underwritten public offering of 690 shares of common stock at a public offering price of $1.74 per share. In addition, the Company sold 345 warrants, at a public offering price of $0.01 per warrant, to purchase shares of Common Stock. The warrants expire on May 18, 2021 and have an exercise price of $2.175 per share. The Company raised gross cash proceeds of $1,204 before deducting underwriting discounts and commissions and other offering expenses of $780. As a result of the consummation of the offering, each series of the Company's outstanding preferred stock, including accrued and unpaid dividends through May 19, 2016, were converted into shares of common stock. As a result of the Amendments to the Certificates of Designations to all classes of Preferred Stock and pursuant to the terms thereof, the conversion price of the Company's Preferred Stock was reduced. The following table summarizes the change in conversion price, the number of shares outstanding as of the conversion date and the number of Common Stock issued upon conversion of the Preferred Stock. Class of Preferred Stock Old Adjusted Shares Common Series A-1 $ 175.00 $ 19.44 976 50 Series B $ 54.13 $ 12.96 14,042 1,083 Series C $ 28.13 $ 9.71 5,702 587 Series D-1 $ 28.13 $ 7.24 8,386 1,159 Series D-2 $ 62.50 $ 8.58 6,625 773 Total 35,731 3,652 The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. In conjunction with the sale of Common Stock, $1,188 of Short-term debt including accrued interest of $120 was converted into 683 shares of the Company's Common Stock. The Company issued 854 warrants with the conversion of the Short-term debt. The Company ascribed a relative fair value of $586 to the warrants using the Black-Scholes-Merton valuation model, which was charged to additional paid-in capital during the quarter ended June 30, 2016. In addition to the conversion of the Short-term debt, approximately $498 of deferred compensation including accrued interest of $59 was converted into 286 shares of the Company's Common Stock. The Company issued 352 warrants with the conversion of the deferred compensation. The Company ascribed a relative fair value of $244 to the warrants using the Black-Scholes-Merton valuation model, which was charged to additional paid- in capital during the quarter ended June 30, 2016. The conversion price of the Short-term debt and deferred compensation was $1.74 per share. The warrants expire on May 18, 2021 and have an exercise price of $2.175. Information with respect to in-kind dividends issued on the Company's Preferred stock for the three and six-month periods ended June 30, 2016 and June 30, 2015 is as follows: Dividends Beneficial Conversion Feature Related to dividends Three Months Ended June 30, Six Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 2016 2015 2016 2015 Series A-1 $ 10 $ 17 $ 29 $ 35 $ - $ - $ 3 $ - Series B 182 313 519 615 - - 73 - Series C 74 127 211 250 - - 39 13 Series D-1 108 179 309 324 - - 78 16 Series D-2 85 149 245 292 - - 52 - Total $ 459 $ 785 $ 1,313 $ 1,516 $ - $ - $ 245 $ 29 Warrants A summary of the warrant activity for the six months ended June 30 is as follows: June 30, 2016 June 30, 2015 Shares Weighted Shares Weighted Outstanding at beginning of period 205 $ 35.51 171 $ 36.13 Issued 1,551 $ 2.18 22 $ 28.13 Expired - $ - (13) $ 62.50 Outstanding at end of period 1,756 $ 5.27 180 $ 34.63 Exercisable at end of period 1,756 $ 5.27 180 $ 34.63 A summary of the status of the warrants outstanding and exercisable as of June 30, 2016 is as follows: Number of Warrants Weighted Average Weighted Average 14 0.01 $0.30 105 0.03 $2.06 32 0.01 $0.51 54 0.06 $0.48 1,551 4.38 $1.92 1,756 4.48 $1.85

Nature of business, basis of 14

Nature of business, basis of presentation and summary of significant accounting policies (Policies)	6 Months Ended
	Jun. 30, 2016
Summary of Significant Accounting Policies
Basis of Presentation	Basis of Presentation The financial information contained herein should be read in conjunction with the Company's consolidated audited financial statements and notes thereto included in its Annual Report on Form 10-K for the year ended December 31, 2015. The accompanying unaudited condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America ("GAAP") for complete consolidated financial statements. In the opinion of management, the unaudited condensed consolidated financial statements included in this quarterly report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for a fair presentation of its financial position at the dates presented and the Company's results of operations and cash flows for the periods presented. The Company's interim results are not necessarily indicative of the results to be expected for the entire year.
Going Concern	Going Concern The accompanying unaudited condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred significant cumulative losses since its inception and, at June 30, 2016, the Company's accumulated deficit was $129,395. The Company has primarily met its working capital needs through the sale of debt and equity securities. As of June 30, 2016, the Company's cash balance was $455. These factors raise substantial doubt about the Company's ability to continue as a going concern. There can be no assurance that the Company will be successful in securing adequate capital resources to fund planned operations or that any additional funds will be available to the Company when needed, or if available, will be available on favorable terms or in amounts required by the Company. If the Company is unable to obtain adequate capital resources to fund operations, it may be required to delay, scale back or eliminate some or all of its operations, which may have a material adverse effect on the Company's business, results of operations and ability to operate as a going concern. The unaudited condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Accounting Changes and Recent Accounting Pronouncements	Accounting Changes and Recent Accounting Pronouncements In January 2016, the FASB issued ASU 2016-01, Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. ASU 2016-01 requires all financial assets and liabilities not accounted for under the equity method to be measured at fair value with the changes in fair value recognized in net income. The amendments in this update also require an entity to separately present in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. In addition, the amendments in this update supersede the requirement to disclose the methods and significant assumptions used in calculating the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet for public business entities. Early adoption is not permitted except for the comprehensive income presentation requirement, and the updated guidance requires a prospective application with a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption. The guidance is effective for annual periods after December 15, 2017, and we are currently in the process of evaluating the impact of this new guidance. In February 2016, the Financial Accounting Standards Board (FASB) issued an Accounting Standards Update (ASU) 2016, Leases (Topic 842) intended to improve financial reporting about leasing transactions which requires companies to report capital and operating leases with a term of 12 Months or longer on their balance sheets. Disclosure requirements of the leasing arrangement will include qualitative and quantitative information about the amounts recorded in the financial statements. The guidance is effective for annual periods after December 15, 2018, and we are currently in the process of evaluating the impact of this new guidance In March 2016 the FASB issued ASU No. 2016-09 Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. ASU 2016-09 provides for simplification involving several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. In addition to these simplifications, ASU 2016-09 also eliminates the guidance in Topic 718 that was indefinitely deferred shortly after the issuance of FASB Statement No. 123 (revised 2004), Share-Based Payment. Early adoption is permitted and the application of the guidance is different for each update included within ASU 2016-09. The guidance is effective for annual periods after December 15, 2016, and we are currently in the process of evaluating the impact of this new guidance. In May 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-12 Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients. ASU 2016-12 provides for improvements and practical expedients for specific areas of Topic 606. In April 2016, the FASB issued ASU No. 2016-10 Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing. ASU 2016-10 provides for clarification of two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance. In March 2016, the FASB issued ASU No. 2016-08Revenue from Contracts with Customers (Topic 606) - Principal versus Agent Considerations (Reporting Revenue Gross versus Net). ASU No. 2016-08 requires an entity to determine whether the nature of its promise to provide goods or services to a customer is performed in a principal or agent capacity and to recognize revenue in a gross or net manner based on its principal/agent designation. ASUs 2016-12, 2016-10 and 2016-08 allow for companies to choose to apply the standard retrospectively to each prior reporting period presented (full retrospective application) or retrospectively with the cumulative effect of initially applying the standard as an adjustment to the opening balance of retained earnings of the annual reporting period that includes the date of initial application (modified retrospective application). Each guidance is effective for annual reporting periods beginning after December 15, 2017, including interim periods within that reporting period. Early application is permitted only as of annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. We are currently in the process of evaluating these guidance updates. iSign is in the process of evaluating the impact of this new guidance on the Company's financial position, results of operations and cash flows.
Intangible Assets, Net	The Company performs an intangible asset impairment analysis at least annually or whenever circumstances or events indicate such assets might be impaired. The Company would recognize an impairment charge in the event the net book value of such assets exceeded the future undiscounted cash flows attributable to such assets.
Net loss per share	The Company calculates basic net loss per share based on the weighted average number of shares outstanding, and when applicable, diluted net income per share, which is based on the weighted average number of shares and potential dilutive shares outstanding.
Derivatives policy	The Company has determined that a contract that would otherwise meet the definition of a derivative but is both (a) indexed to the Company's own stock and (b) classified in stockholders' deficit in the statement of financial position would not be considered a derivative financial instrument. The Company applies a two-step model in determining whether a financial instrument or an embedded feature is indexed to an issuer's own stock and thus able to qualify for the scope exception.
Fair value measurement	The fair value framework requires a categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets and liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows: Level 1: Applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2: Applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3: Applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities.
Share-based payment	Stock-based compensation expense is based on the estimated grant date fair value of the portion of stock-based payment awards that are ultimately expected to vest during the period. The grant date fair value of stock-based awards to employees and directors is calculated using the Black-Scholes-Merton valuation model. Forfeitures of stock-based payment awards are estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The estimated average forfeiture rate for the three months ended June 30, 2016 and 2015, was approximately 11.89% and 7.54%, respectively, based on historical data. Valuation and Expense Information: The weighted-average fair value of stock-based compensation is based on the Black-Scholes-Merton valuation model. Forfeitures are estimated and it is assumed no dividends will be declared. The estimated fair value of stock-based compensation awards to employees is amortized using the accrual method over the vesting period of the options.

Concentration (Tables)

Concentration (Tables)	6 Months Ended
	Jun. 30, 2016
Risks and Uncertainties [Abstract]
Schedule of accounts receivable and revenue concentration	The following table summarizes accounts receivable and revenue concentrations: Accounts Receivable Total Revenue Total Revenue 2016 2015 2016 2015 2016 2015 Customer #1 33% 19% - - - - Customer #2 - 32% - 11% - 13% Customer #3 - - - 10% 11% 19% Customer #4 48% 31% 38% 28% 27% 16% Customer #5 - - - - 11% - Total concentration 81% 82% 38% 49% 49% 48%

Intangible Assets (Tables)

Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	The following table summarizes the patents: June 30, 2016 December 31, 2015 Carrying Accumulated Net Value Carrying Accumulated Net Value Amortizable Technology $ 6,745 $ (6,315) $ 430 $ 6,745 $ (6,154) $ 591

Net loss per share (Tables)

Net loss per share (Tables)	6 Months Ended
	Jun. 30, 2016
Net loss per share [Abstract]
Schedule of Antidilutive Securities Excluded from Calculation of Earnings Per Share	The following table lists shares and warrants that were excluded from the calculation of diluted earnings per share as the exercise of such options and warrants and the conversion of such preferred shares would be anti-dilutive: For the Six Months Ended June 30, 2016 June 30, 2015 Stock options 74 85 Warrants 1,756 179 Preferred Stock as if converted Series A-1 Preferred Stock - 5 Series B Preferred Stock - 237 Series C Preferred Stock - 185 Series D-1 Preferred Stock - 261 Series D-2 Preferred Stock - 97

Derivative Liability (Tables)

Derivative Liability (Tables)	6 Months Ended
	Jun. 30, 2016
Derivative liability [Abstract]
Fair value assumptions used in valuation techniques	The Company used a Monte Carlo simulation to value the conversion feature with the following assumptions: As of June 30, 2016 Common Stock price $ 1.31 Convertible debt principal amount $ 200 Term (years) 0.32 Expected volatility 108% Convertible debt interest rate 24% Trials (each trial equals 150,000 iterations) 10 Discount to IPO/next round Based upon a Company pre-money valuation of $5,000
Changes in the market value of the Level 3 derivative liability	Changes in the fair market value of the Level 3 derivative liability for the six-month periods ended June 30, 2016 and June 30, 2015 are as follows: For the Six Months Ended June 30, 2016 June 30, 2015 Balance at January 1 $ 330 $ - Net gain on derivative liability (174) - Balance at June 30 $ 156 $ -

Equity (Tables)

Equity (Tables)	6 Months Ended
	Jun. 30, 2016
Stockholders' Equity [Abstract]
Key assumptions for fair value calculation, stock options	The fair value calculations are based on the following assumptions: Six Months Ended Six Months Ended Risk free interest rate 0.04% - 3.19% 0.04% - 3.73% Expected life (years) 2.82 - 7.00 3.26 - 6.88 Expected volatility 112.75% - 198.90% 93.63% - 198.38% Expected dividends None None
Allocation of stock-based compensation expense related to stock option grants	The following table summarizes the allocation of stock-based compensation expense related to stock option grants for the three and six months ended June 30: Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 Research and development $ 15 $ 47 $ 34 $ 113 Sales and marketing $ 2 $ 34 $ 15 $ 86 General and administrative $ 19 $ 65 $ 43 $ 145 Director options $ 6 $ 12 $ 14 $ 27 Total stock-based compensation expense $ 42 $ 158 $ 106 $ 371
Summary of option activity	A summary of option activity under the Company's plans for the six months ended June 30, 2016 and 2015 is as follows: Options 2016 2015 Shares Weighted Price Per Share Weighted Life (Years) Aggregate Value Shares Weighted Price Per Share Weighted Life (Years) Aggregate Value Outstanding at January 1, 82 $ 45.35 $ - 57 $ 56.13 $ - Granted - $ - $ - 29 $ 28.13 $ - Exercised - $ - $ - - $ - $ - Forfeited or expired (8) $ 42.16 $ - (1) $ 37.50 $ - Outstanding at June 30 74 $ 45.71 3.65 $ - 85 $ 46.75 4.59 $ - Vested and expected to vest at June 30 72 $ 46.22 3.10 $ - 83 $ 37.50 3.24 $ - Exercisable at June 30 58 $ 51.10 3.10 $ - 52 $ 56.00 3.56 $ -
Summary of the significant ranges of outstanding and exercisable options	The following table summarizes significant ranges of outstanding and exercisable options as of June 30, 2016: Range of Exercise Prices Options Outstanding Options Exercisable Number Weighted Weighted Number Weighted $25.00 - $625.00 74 3.65 $ 45.71 58 $ 51.10
Summary of the status of the Company's non-vested shares	A summary of the status of the Company's non-vested shares as of June 30, 2016 is as follows: Non-vested Shares Shares Weighted Non-vested at January 1, 2016 25 $28.61 Forfeited (3) $28.80 Vested (6) $46.22 Non-vested at June 30, 2016 16 $26.42
Information with respect to dividends issued on the Company's preferred stock	The following table summarizes the change in conversion price, the number of shares outstanding as of the conversion date and the number of Common Stock issued upon conversion of the Preferred Stock. Class of Preferred Stock Old Adjusted Shares Common Series A-1 $ 175.00 $ 19.44 976 50 Series B $ 54.13 $ 12.96 14,042 1,083 Series C $ 28.13 $ 9.71 5,702 587 Series D-1 $ 28.13 $ 7.24 8,386 1,159 Series D-2 $ 62.50 $ 8.58 6,625 773 Total 35,731 3,652
Summary of the warrants issued	Information with respect to in-kind dividends issued on the Company's Preferred stock for the three and six-month periods ended June 30, 2016 and June 30, 2015 is as follows: Dividends Beneficial Conversion Feature Related to dividends Three Months Ended June 30, Six Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, 2016 2015 2016 2015 2016 2015 2016 2015 Series A-1 $ 10 $ 17 $ 29 $ 35 $ - $ - $ 3 $ - Series B 182 313 519 615 - - 73 - Series C 74 127 211 250 - - 39 13 Series D-1 108 179 309 324 - - 78 16 Series D-2 85 149 245 292 - - 52 - Total $ 459 $ 785 $ 1,313 $ 1,516 $ - $ - $ 245 $ 29
Status of the warrants outstanding	A summary of the warrant activity for the six months ended June 30 is as follows: June 30, 2016 June 30, 2015 Shares Weighted Shares Weighted Outstanding at beginning of period 205 $ 35.51 171 $ 36.13 Issued 1,551 $ 2.18 22 $ 28.13 Expired - $ - (13) $ 62.50 Outstanding at end of period 1,756 $ 5.27 180 $ 34.63 Exercisable at end of period 1,756 $ 5.27 180 $ 34.63
Information with respect to the classes of Preferred Stock	A summary of the status of the warrants outstanding and exercisable as of June 30, 2016 is as follows: Number of Warrants Weighted Average Weighted Average 14 0.01 $0.30 105 0.03 $2.06 32 0.01 $0.51 54 0.06 $0.48 1,551 4.38 $1.92 1,756 4.48 $1.85

Nature of business, basis of 20

Nature of business, basis of presentation and summary of significant accounting policies (Details Textual) $ in Thousands	Jan. 22, 2016	Jan. 31, 2016	Jun. 30, 2016USD ($)	Dec. 31, 2015USD ($)	Jun. 30, 2015USD ($)	Dec. 31, 2014USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated deficit			$ (129,395)	$ (127,116)
Cash and Cash Equivalents, at Carrying Value			$ 455	$ 846	$ 409	$ 775
Reverse stock split, description		On January 21, 2016, iSign Solutions Inc (the Company or iSign) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation (the Certificate of Amendment) with the Secretary of State of the State of Delaware to effect a 1-for-1,250 reverse split of the Company outstanding shares of common stock. The reverse split became effective at 9:01 a.m. on January 22, 2016. The information with respect to common stock for the years ended December 31, 2015 and 2014 have been retroactively restated to give effect to the 1-for-1,250 reverse split.
Stockholders' Equity Note, Stock Split, Conversion Ratio	1,250	1

Concentrations (Details)

Concentrations (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Accounts Receivable [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			81.00%	82.00%
Accounts Receivable [Member] | Customer One [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			33.00%	19.00%
Accounts Receivable [Member] | Customer Two[Member]
Concentration Risk [Line Items]
Concentration risk, percentage				32.00%
Accounts Receivable [Member] | Customer Four [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			48.00%	31.00%
Sales Revenue, Services, Net [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.00%	49.00%	49.00%	48.00%
Sales Revenue, Services, Net [Member] | Customer Two[Member]
Concentration Risk [Line Items]
Concentration risk, percentage		11.00%		13.00%
Sales Revenue, Services, Net [Member] | Customer Three [Member]
Concentration Risk [Line Items]
Concentration risk, percentage		10.00%	11.00%	19.00%
Sales Revenue, Services, Net [Member] | Customer Four [Member]
Concentration Risk [Line Items]
Concentration risk, percentage	38.00%	28.00%	27.00%	16.00%
Sales Revenue, Services, Net [Member] | Customer Five [Member]
Concentration Risk [Line Items]
Concentration risk, percentage			11.00%

Intangible Assets (Details)

Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Amortizable intangible assets
Finite-Lived Intangible Assets, Net	$ 430	$ 591
Technology [Member]
Amortizable intangible assets
Finite-lived intangible assets, gross	6,745	6,745
Finite-Lived intangible assets, accumulated amortization	(6,315)	(6,154)
Finite-Lived Intangible Assets, Net	$ 430	$ 591

Intangible Assets (Details Text

Intangible Assets (Details Textual) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Patent amortization expense	$ 80	$ 86	$ 161	$ 173
Patents impairment	$ 0	$ 0	$ 0	$ 0

Net loss per share (Details)

Net loss per share (Details) - shares shares in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Series A Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares		5
Series B Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares		237
Series C Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares		185
Series D One Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares		261
Series D Two Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares		97
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares	74	85
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, shares	1,756	179

Debt (Details Texual)

Debt (Details Texual) $ / shares in Units, shares in Thousands, $ in Thousands	May 19, 2016USD ($)$ / sharesshares	Dec. 31, 2015USD ($)$ / sharesshares	Jun. 30, 2016USD ($)$ / sharesshares	Jun. 30, 2015$ / sharesshares	Dec. 31, 2014$ / sharesshares
Short-term Debt [Line Items]
Number of warrants | shares		205	1,756	180	171
Warrants exercise price | $ / shares		$ 35.51	$ 5.27	$ 34.63	$ 36.13
Fair value of the derivative liability			$ 156
Debt discount amortization			266
Unsecured Convertible Promissory Notes [Member] | Investors and Affiliates [Member]
Short-term Debt [Line Items]
Proceeds from issuance of short-term debt		$ 1,268
Principal amount of unsecured convertible promissory note	$ 1,068		$ 190
Conversion price | $ / shares	$ 1.74
Common shares issued in connection with the conversion of promissory notes | shares	683
Number of warrants | shares	854
Number of common shares callable by warrants | shares	854
Warrants term	5 years
Warrants exercise price | $ / shares	$ 2.175
Terms of debt conversion feature			The note can be converted into shares of our Common Stock at the holders option for a period of 60 days after maturity, at a conversion price based upon a Company pre-money valuation of $5,000. Upon such conversion, the holder would also receive cash payments, payable from 3% of the revenue received by the Company from its European customer, not to exceed three times the aggregate principal amount of $200.
Stated percentage of loans borrowed			24.00%
Promissory notes due date			Aug. 25, 2016
Threshold percentage of stock price trigger			30.00%
Threshold trading days | $ / shares			60
Company pre-money valuation amount			$ 5,000
Percentage of cash payments paid based on each $100,000 of notes converted from the revenue			3.00%
Incremental amount of notes converted into revenue received that serves as basis for calculation of cash payments			$ 200
Fair value of the derivative liability	$ 586
Debt discount amortization			$ 10

Derivative Liability (Details)

Derivative Liability (Details) - Derivative Financial Instruments, Liabilities [Member] $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2016USD ($)$ / shares
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Common Stock price | $ / shares	$ 1.31
Convertible debt principal amount | $	$ 200
Term (years)	3 months 25 days
Expected volatility	108.00%
Convertible debt interest rate	24.00%
Trials (each trial equals 150,000 itirations)	10
Discount to IPO/next Round	Based upon a Company pre-money valuation of $5,000

Derivative Liability (Details P

Derivative Liability (Details Parenthetical) - Derivative Financial Instruments, Liabilities [Member] $ in Thousands	Jun. 30, 2016USD ($)
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Number of itirations in each Monte Carlo simulation trial	150,000
Pre-money valuation	$ 5,000

Derivative Liability (Details 1

Derivative Liability (Details 1) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at end of period	$ 156
Derivative Financial Instruments, Liabilities [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	330
Gain on derivative liability	(174)
Balance at end of period	$ 156

Derivative Liability (Details T

Derivative Liability (Details Textual) $ in Thousands	Jun. 30, 2016USD ($)
Derivative Liability, Fair Value, Net [Abstract]
Fair value of the derivative liability	$ 156

Equity (Details)

Equity (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract]
Risk-free interest rate, minimum	0.04%	0.04%
Risk-free interest rate, maximum	3.19%	3.73%
Expected volatility, minimum	112.75%	93.69%
Expected volatility, maximum	198.90%	198.38%
Expected dividend yield	$ 0	$ 0
Minimum [Member]
Fair value assumptions, stock options
Expected life	2 years 9 months 25 days	3 years 3 months 4 days
Maximum [Member]
Fair value assumptions, stock options
Expected life	7 years	6 years 10 months 17 days

Equity (Details 1)

Equity (Details 1) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 42	$ 158	$ 106	$ 371
Research and Development Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	15	47	34	113
Selling and Marketing Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	2	34	15	86
General and Administrative Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	19	65	43	145
Director Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 6	$ 12	$ 14	$ 27

Equity (Details 2)

Equity (Details 2) - USD ($) shares in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Summary of stock options outstanding
Stock Options Outstanding, Beginning Balance	82	57
Stock Options, Granted		29
Stock Options, Exercised
Stock Options, Forfeited, or expired	(8)	(1)
Stock Options Outstanding, Ending Balance	74	85
Stock Options, Vested and expected to vest at ending balance	72	83
Options exercisable	58	52
Weighted Average Exercise Price, Beginning Period	$ 45.35	$ 56.13
Weighted Average Exercise Price, Granted		28.13
Weighted Average Exercise Price, Forfeited, or expired	42.16	37.50
Weighted Average Exercise Price, Ending Period	45.71	46.75
Weighted Average Exercise Price, Vested and expected to vest at ending balance	46.22	37.50
Weighted Average Exercise Price, Exercisable at ending balance	$ 51.10	$ 56
Weighted Average Remaining Contractual Term, ending balance	3 years 7 months 24 days	4 years 7 months 24 days
Weighted Average Remaining Contractual Term, vested and expected to vest at ending balance	3 years 1 month 6 days	3 years 2 months 26 days
Weighted Average Remaining Contractual Term, excercisable at ending balance	3 years 1 month 6 days	3 years 6 months 21 days
Aggregate Intrinsic Value, Beginning Balance
Aggregate Intrinsic Value, Granted
Aggregate Intrinsic Value, Exercised
Aggregate Intrinsic Value, Forfeited or expired
Aggregate Intrinsic Value, Ending Balance
Aggregate Intrinsic Value, Vested and expected to vest at ending balance
Aggregate Intrinsic Value, Exercisable at ending balance

Equity (Details 3)

Equity (Details 3) - $ / shares shares in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract]
Outstanding Options, Weighted Average Exercise Price		$ 28.13
Range One [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise Price Range, Lower Range Limit	$ 25
Exercise Price Range, Upper Range Limit	$ 625
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, End of Period [Abstract]
Number of Outstanding Options	74
Outstanding Options, Weighted Average Remaining Contractual Term	3 years 6 months 21 days
Outstanding Options, Weighted Average Exercise Price	$ 45.71
Exercise Price Range, Number of Exercisable Options	58
Exercisable Options, Weighted Average Exercise Price	$ 51.10

Equity (Details 4)

Equity (Details 4) shares in Thousands	6 Months Ended
	Jun. 30, 2016$ / sharesshares
Equity Instruments, Options, Nonvested Shares Roll-Forward
Non-vested shares, Beginning Balance | shares	25
Non-vested shares, forfeited, or expired | shares	(3)
Non-vested shares, vested | shares	(6)
Stock Options Outstanding, Ending Balance | shares	16
Weighted Average Grant Date Fair Value, Options Nonvested at beginning of period | $ / shares	$ 28.61
Weighted Average Grant Date Fair Value, Options nonvested, forfeited in period | $ / shares	28.80
Weighted Average Grant Date Fair Value, Options nonvested, vested in period | $ / shares	46.22
Weighted Average Grant Date Fair Value, Options nonvested at end of period | $ / shares	$ 26.42

Equity (Details 5)

Equity (Details 5) shares in Thousands	May 19, 2016$ / sharesshares
Shares Outstanding at Conversion Date	35,731
Convertible Preferred Stock, Shares Issued upon Conversion	3,652
Series A Preferred Stock [Member]
Old Conversion Price | $ / shares	$ 175
Adjusted Conversion Price | $ / shares	$ 19.44
Shares Outstanding at Conversion Date	976
Convertible Preferred Stock, Shares Issued upon Conversion	50
Series B Preferred Stock [Member]
Old Conversion Price | $ / shares	$ 54.13
Adjusted Conversion Price | $ / shares	$ 12.96
Shares Outstanding at Conversion Date	14,042
Convertible Preferred Stock, Shares Issued upon Conversion	1,083
Series C Preferred Stock [Member]
Old Conversion Price | $ / shares	$ 28.13
Adjusted Conversion Price | $ / shares	$ 9.71
Shares Outstanding at Conversion Date	5,702
Convertible Preferred Stock, Shares Issued upon Conversion	587
Series D One Preferred Stock [Member]
Old Conversion Price | $ / shares	$ 28.13
Adjusted Conversion Price | $ / shares	$ 7.24
Shares Outstanding at Conversion Date	8,386
Convertible Preferred Stock, Shares Issued upon Conversion	1,159
Series D Two Preferred Stock [Member]
Old Conversion Price | $ / shares	$ 62.50
Adjusted Conversion Price | $ / shares	$ 8.58
Shares Outstanding at Conversion Date	6,625
Convertible Preferred Stock, Shares Issued upon Conversion	773

Equity (Details 6)

Equity (Details 6) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Dividends Net of Beneficial Conversion Feature	$ 459	$ 785	$ 1,313	$ 1,516
Accretion of beneficial conversion feature related to dividends			245	29
Series A Preferred Stock [Member]
Dividends Net of Beneficial Conversion Feature	10	17	29	35
Accretion of beneficial conversion feature related to dividends			3
Series B Preferred Stock [Member]
Dividends Net of Beneficial Conversion Feature	182	313	519	615
Accretion of beneficial conversion feature related to dividends			73
Series C Preferred Stock [Member]
Dividends Net of Beneficial Conversion Feature	74	127	211	250
Accretion of beneficial conversion feature related to dividends			39	13
Series D One Preferred Stock [Member]
Dividends Net of Beneficial Conversion Feature	108	179	309	324
Accretion of beneficial conversion feature related to dividends			78	16
Series D Two Preferred Stock [Member]
Dividends Net of Beneficial Conversion Feature	85	149	245	292
Accretion of beneficial conversion feature related to dividends			$ 52

Equity (Details 7)

Equity (Details 7) shares in Thousands	6 Months Ended
	Jun. 30, 2016$ / sharesshares	Jun. 30, 2015$ / sharesshares
Class Of Warrant Or Right Number Of Warrants Or Rights Roll Forward
Number of Warrants Outstanding at beginning of period | shares	205	171
Number of warrants issued | shares	1,551	22
Number Of Warrants Or Rights Expired | shares		(13)
Number of Warrants Outstanding at end of period | shares	1,756	180
Number of Warrants Or Rights Exercisable at end of period | shares	1,756	180
Excercise Price of Warrants Outstanding at beginning of period | $ / shares	$ 35.51	$ 36.13
Exercise Price Of Warrants Issued | $ / shares	2.18	28.13
Exercise Price Of Warrants Expired | $ / shares		62.50
Excercise Price of Warrants Outstanding at end of period | $ / shares	$ 5.27	$ 34.63
Exercise Price Of WarrantsExercisable at end of period | $ / shares	5.27	34.63

Equity (Details 8)

Equity (Details 8) - $ / shares shares in Thousands	6 Months Ended
	Jun. 30, 2016	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014
Class of Warrant or Right [Line Items]
Number of Warrants Outstanding and Excercisable	1,756	205	180	171
Weighted Average Remaining Life Of Warrants Or Rights	4 years 4 months 17 days
Warrants Weighted Average Exercise Price per share	$ 1.85
Warrants Group One [Member]
Class of Warrant or Right [Line Items]
Number of Warrants Outstanding and Excercisable	14
Weighted Average Remaining Life Of Warrants Or Rights	4 days
Warrants Weighted Average Exercise Price per share	$ 0.30
Warrants Group Two [Member]
Class of Warrant or Right [Line Items]
Number of Warrants Outstanding and Excercisable	105
Weighted Average Remaining Life Of Warrants Or Rights	10 days
Warrants Weighted Average Exercise Price per share	$ 2.06
Warrants Group Three [Member]
Class of Warrant or Right [Line Items]
Number of Warrants Outstanding and Excercisable	32
Weighted Average Remaining Life Of Warrants Or Rights	4 days
Warrants Weighted Average Exercise Price per share	$ 0.51
Warrants Group Four [Member]
Class of Warrant or Right [Line Items]
Number of Warrants Outstanding and Excercisable	54
Weighted Average Remaining Life Of Warrants Or Rights	21 days
Warrants Weighted Average Exercise Price per share	$ 0.48
Warrants Group Five [Member]
Class of Warrant or Right [Line Items]
Number of Warrants Outstanding and Excercisable	1,551
Weighted Average Remaining Life Of Warrants Or Rights	4 years 4 months 17 days
Warrants Weighted Average Exercise Price per share	$ 1.92

Equity (Details Textual)

Equity (Details Textual) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Share-based Arrangements with Employees and Nonemployees [Abstract]
Estimated average forfeiture rate	11.89%	7.54%
Stock Options, Granted		29
Outstanding Options, Weighted Average Exercise Price		$ 28.13
Stock Options, Exercised
Total unrecognized compensation expense related to non-vested share-based compensation arrangements granted under the plans	$ 107
Unrecognized compensation expense amortization period	1 year 8 months 12 days

Equity (Details Textual 1)

Equity (Details Textual 1) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	May 19, 2016	Jun. 30, 2016	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014
Subsidiary, Sale of Stock [Line Items]
Warrants Weighted Average Exercise Price		$ 5.27	$ 35.51	$ 34.63	$ 36.13
Number of warrants		1,756	205	180	171
Fair value of the derivative liability		$ 156
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of stock, net	$ 1,204
Administrative and other offering expenses	$ 780
Number of shares sold in private placement	690
Warrants Weighted Average Exercise Price	$ 2.175
Warrants, expiration date	May 18, 2021
Public offering price	$ 1.74
Number of warrants	345
Warrants offering price	$ 0.01
Note Conversion [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of stock, net	$ 1,188
Number of shares sold in private placement	683
Warrants Weighted Average Exercise Price	$ 2.175
Warrants, expiration date	May 18, 2021
Number of warrants	854
Debt Instrument, Increase, Accrued Interest	$ 120
Fair value of the derivative liability	$ 586
Conversion price	$ 1.74
Deferred Compensation Conversion [Member]
Subsidiary, Sale of Stock [Line Items]
Proceeds from sale of stock, net	$ 498
Number of shares sold in private placement	286
Warrants Weighted Average Exercise Price	$ 2.175
Warrants, expiration date	May 18, 2021
Number of warrants	352
Debt Instrument, Increase, Accrued Interest	$ 59
Fair value of the derivative liability	$ 244
Conversion price	$ 1.74